Linner Mercury vs Resound Vivia 9 60S microRIE

The Linner Mercury is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.1/5 in our lab testing. Priced at $387, it ranks #60 of 65 devices in the OTC Hearing Aid category, placing it in the top 91% of the category. In our testing, the Mercury shows a mixed performance profile. Its standout strength is excellent feedback handling at 4.7/5, which is 0.16 points above the category average—meaning users are unlikely to experience whistling or squealing during normal use. However, speech clarity metrics fall below category norms: speech in quiet scores 2.2/5 (0.62 points below average), and speech in noise scores a low 1.0/5 (0.48 points below average). Own-voice comfort also scores low at 1.6/5, sitting 0.91 points below the category average. Music streaming is a notable weakness, scoring 0.0/5—a full 1.92 points below the category average. Users who prioritize streaming audio from their phone should consider alternatives. The device uses a rechargeable battery and features a visible in-ear design with power dome coupling. At this price point, several competitors offer stronger overall performance. The Linner Mercury may appeal to budget-conscious consumers who prioritize feedback-free operation over speech clarity and streaming quality, but those seeking better speech understanding in challenging environments should explore higher-scoring options in this price range.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.